Forbion Capital invests in Sanifit's $41 mln round
Sanifit raised 36.6 million Euros (US$41 million) in a Series C round of financing. Forbion Capital Partners took part in the round as well as Ysios Capital, Lundbeckfond Ventures, Gilde Healthcare, Edmond de Rothschild Investment Partners, “la Caixa” and Baxter Healthcare. Existing shareholders also supported the series C round. Sanifit is a Spanish clinical-stage biopharmaceutical company.
8 September 2015•5 mins read
